UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

Form 8-A

 

 

FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES

PURSUANT TO SECTION 12(b) OR 12(g) OF THE

SECURITIES EXCHANGE ACT OF 1934

 

 

PHIBRO ANIMAL HEALTH CORPORATION

(Exact name of registrant as specified in its charter)

 

 

 

     
Delaware 13-1840497

(State of incorporation

or organization)

(I.R.S. Employer

Identification No.)

   

Glenpointe Centre East, 3rd Floor

300 Frank W. Burr Boulevard, Suite 21

Teaneck, New Jersey

 07666-6712
(Address of principal executive offices) (Zip Code)

 

 

Securities to be registered pursuant to Section 12(b) of the Act:

 

     

Title of each class

to be so registered

 Name of each exchange on which
each class is to be registered

Class A Common Stock,

$0.0001 par value per share

 The NASDAQ Stock Market LLC

If this form relates to the registration of a class of securities pursuant to Section 12(b) of the Exchange Act and is effective pursuant to General Instruction A.(c), check the following box.  x

If this form relates to the registration of a class of securities pursuant to Section 12(g) of the Exchange Act and is effective pursuant to General Instruction A.(d), check the following box.  ¨

Securities Act registration statement file number to which this form relates: 333-194467

Securities to be registered pursuant to Section 12(g) of the Act: None

 

 

 
 

 

Item 1.  Description of Registrant’s Securities to be Registered

 

The description of the Class A Common Stock, $0.0001 par value per share, of Phibro Animal Health Corporation, a Delaware corporation, as set forth under the caption “Description of Capital Stock” in the prospectus forming a part of the Registration Statement on Form S-1, as originally filed with the Securities and Exchange Commission (the “Commission”) on March 10, 2014 (Registration No. 333-194467), including exhibits, and as may be subsequently amended from time to time (the “Registration Statement”), is hereby incorporated by reference. In addition, all of the above-referenced descriptions included in any prospectus relating to the Registration Statement filed with the Commission pursuant to Rule 424(b) under the Securities Act of 1933, as amended, shall be deemed to be incorporated by reference herein.

Item 2.  Exhibits

 

Pursuant to the Instructions as to Exhibits for Form 8-A, no exhibits are required to be filed, because no other securities of the Registrant are registered on The NASDAQ Stock Market LLC, and the securities registered hereby are not being registered pursuant to Section 12(g) of the Securities Exchange Act of 1934, as amended.

 

 
 

 

 

SIGNATURE

Pursuant to the requirements of Section 12 of the Securities Exchange Act of 1934, the registrant has duly caused this registration statement to be signed on its behalf by the undersigned, thereto duly authorized.

 

 

  PHIBRO ANIMAL HEALTH CORPORATION
   
Dated: April 8, 2014  
  By:  /s/ Thomas G. Dagger
  Name: 
Title:		 Thomas G. Dagger
Senior Vice President, General Counsel and Corporate Secretary